Institutional Cluster

BVS

Bioventus Inc.
MIXED
Impact 5/10
Horizonweeks Processed1mo ago
Institutional cluster: 9 buyers, 5 sellers (mixed)
Actionable Insight ◆ Mixed

The institutional buying cluster is a modest positive signal, particularly the active-manager conviction (American Century doubling, Dimensional adding 29%), but the poor historical T+20 returns on BVS calls and lack of insider buying suggest caution. The strategic alternatives review creates a binary event — a premium takeout could reward current holders, but failure to find a buyer could trigger a sharp reversion. Monitor for 13D filings or further insider buying as confirmation of the takeout thesis.

DirectionMixed
Confidencemedium
Horizonweeks
Latest settled — T+20d
BVS ▼ -5.19% at T+20d
NEUTRAL call ✗ call lost -5.19% · α vs SPY -3.66% · entry $13.88 → $13.16
Next anchor: T+60d in 5w
Latest observation: T+32 -20.48% FF3 residual α
Entry anchored
Aug 14, 04:00 PM ET
via 1-min bar
T+1d
+3.03%
call +3.03% · α +3.70%
$14.30
settled 7w ago
T+5d
+1.01%
call +1.01% · α +2.20%
$14.02
settled 6w ago
T+20d
-5.19%
call -5.19% · α -3.66%
$13.16
settled 18d ago
T+60d
—
call — · α —
—
in 5w

Executive Summary

A mixed institutional cluster formed in BVS during Q2 2026, with 9 buyers accumulating $12.9M in net new positions (dominated by American Century Companies doubling to $12.8M and Dimensional Fund Advisors adding $2.7M) against 5 sellers trimming $1.2M. The buying cluster is heavily weighted toward active asset managers (7 of 9 buyers) and follows the company's August 5 earnings report and formal strategic alternatives review, suggesting institutions are positioning for a potential premium takeout. However, the stock's poor historical performance (avg -15.2% T+20 across prior reports) and the absence of insider buying caution against aggressive bullish positioning.

Key Financial Metrics

Direction
accumulating
Buy Value
$32.4M
Sell Value
$1.2M
Net Flow
$12.9M

Institutional Positions

Net institutional flow: $12.9M

▲ Buyers (9)

InstitutionActionChangePosition ValueValue Δ
American Century CompaniesDOUBLED+118.4%$12.8M$7.1M
Dimensional Fund AdvisorsADD+29.2%$10.7M$2.7M
Goldman SachsADD+37.8%$6.2M$1.8M
JPMorganADD+51.9%$1.5M$581.0K
CitigroupDOUBLED+1481.5%$365.0K$343.0K

▼ Sellers (5)

InstitutionActionChangePrev ValueValue Δ
Morgan StanleyTRIM-25.1%$2.4M-$534.0K
BofATRIM-44.7%$786.0K-$336.3K
Panagora Asset ManagementTRIM-25.9%$1.2M-$278.1K

Key Facts

  • 9 institutional buyers added $12.9M net, led by American Century Companies ($7.1M increase to $12.8M) and Dimensional Fund Advisors ($2.7M increase to $10.7M)
  • 5 sellers trimmed $1.2M, led by Morgan Stanley (-$534K) and BofA (-$336K)
  • Active asset managers dominate the buying (7 of 9 buyers), not passive rebalancing
  • Cluster follows Q2 2026 earnings (revenue $153.2M, +4% YoY, slightly below consensus) and formal strategic alternatives review announced Aug 5
  • No insider open-market buying during the window, per 13F × Form 4 confluence score of 34/100
  • Historical model performance on BVS is poor: avg -15.2% T+20 across 8 settled reports, 13% win rate

Financial Impact

Net institutional buying of $12.9M against $1.2M in selling, with total buyer holdings of $32.4M representing a significant portion of BVS's ~$400M market cap

institutional ownershipfloat concentration

Risk Factors

  • Strategic alternatives review may not result in a sale, leading to disappointment
  • Revenue growth of only 4% YoY and a slight consensus miss suggest limited organic momentum
  • Historical model calibration shows BVS calls underperform significantly at T+20 (avg -15.2%)
  • No insider buying to corroborate institutional conviction

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-BVS-2026-Q2
13 reports for BVS
Performance horizon
44% Hit rate 4 of 9 directional calls best @ T+60▲ +27.81%May 8, 2026
Filters
Rows
Reports for BVS — sortable, filterable
TypeNow
Aug 15, 2026
6w ago
Institutional Cluster
MIXED ★ 5/10
$13.88 $13.16▼ −5.19%▼ −3.66%—
Aug 5, 2026
8w ago
8-K
BULLISH ★ 7/10
$15.26 $14.37▼ −5.83%▼ −5.23%—
Aug 5, 2026
8w ago
Press Release
BULLISH ★ 7/10
$15.26 $14.37▼ −5.83%▼ −5.23%—
Jun 11, 2026
16w ago
Institutional Cluster
BEARISH ★ 4/10
$8.68 $12.22▼ −40.78%▼ −38.89%—
Jun 2, 2026
17w ago
Press Release
BEARISH ★ 6/10
$8.11 $9.85▼ −21.45%▼ −23.02%—
May 21, 2026
19w ago
8-K
NEUTRAL ★ 3/10
$9.28 $8.99▼ −3.13%▼ −1.71%—
May 8, 2026
21w ago
Court Ruling
BULLISH ★ 5/10
$10.50 $9.04▼ −13.90%▼ −13.93%—
May 6, 2026
21w ago
8-K
BULLISH ★ 7/10
$10.92 $8.55▼ −21.70%▼ −24.48%—
May 6, 2026
21w ago
Press Release
BULLISH ★ 8/10
$10.92 $8.55▼ −21.70%▼ −24.48%—
Apr 28, 2026
22w ago
Press Release
NEUTRAL ★ 2/10
$9.67 $8.87▼ −8.27%▼ −14.32%—
Showing 10 of 13

US Market Status

Market Closed — Opens Mon (38h 38m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 15, 2026